Sr Manager, Data Science & Advanced Analytics

• Lead design and delivery of advanced analytics initiatives, including predictive modeling, segmentation, and optimization.
• Build and maintain automated reporting and data pipelines using tools such as Power BI, Tableau, and Snowflake.
• Apply statistical and machine learning techniques to extract insights from structured and unstructured data.
• Ensure data quality, integrity, and security across analytics processes translating raw data into useable data.
• Translate complex analytics into actionable insights for commercial, sales, and operations teams.
• Drive adoption of best practices and innovative methodologies across analytics teams.

• Legally authorized to work in the U.S.
• Commutable distance to Stamford, CT.
• Master’s degree in Data Science, Statistics, Computer Science, Business Analytics, or related field.
• 10+ years in data analytics/data science, including 5+ years in leadership roles within CPG or regulated industries.
• Advanced proficiency in SQL, Python, R, and BI tools (Power BI, Tableau).
• Proven experience with syndicated market data, retailer scan/loyalty data, and CPG analytics use cases.
• Demonstrated success in managing multiple analytics projects and cross-functional stakeholders.
• Strong communication skills for presenting complex data to non-technical audiences.
• Relevant certifications (e.g., AI/ML, PMP) preferred.

• We offer a competitive base salary, annual bonus (applicable based on level of position), great medical, dental and vision coverage, 401k with a generous company match, incredible wellness benefits, commuter benefits, pet insurance, generous PTO, and much more!

At Philip Morris International (PMI), we’ve chosen to do something incredible. We’re totally transforming our business and building our future on one clear purpose - to deliver a smoke-free future.

With huge change, comes huge opportunity. So, if you join us, you’ll enjoy the freedom to dream up and deliver better, brighter solutions and the space to move your career forward in endlessly different directions. Our success depends on people who are committed to our purpose and have an appetite for progress.

Our beautiful HQ in Stamford, CT is just steps away from the Stamford Metro-North Train Station and easily accessible from NYC. (Only Include if position is based in Stamford), * We have implemented Smart Work, a hybrid model of working that promotes flexibility in the workplace.

• Seize the freedom to define your future and ours. We’ll empower you to take risks, experiment and explore.
• Be part of an inclusive, diverse culture where everyone’s contribution is respected; Collaborate with some of the world’s best people and feel like you belong.
• Pursue your ambitions and develop your skills with a global business - our staggering size and scale provides endless opportunities to progress.
• Take pride in delivering our promise to society: To improve the lives of millions of smokers.

PMI is an Equal Opportunity Employer.

PMI is headquartered in Stamford, Conn., and its U.S. affiliates have more than 3,000 employees., PMI has been an entirely separate company from Altria and Philip Morris USA since 2008. PMI’s affiliates first entered the U.S. market following the company’s acquisition of Swedish Match in late 2022. Philip Morris International and its U.S. affiliates are working to deliver a smoke-free future. Since 2008, PMI has invested $12.5 billion globally to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke with the goal of transitioning legal-age consumers who smoke to better alternatives. In 2022, PMI acquired Swedish Match - a leader in oral nicotine delivery - creating a global smoke-free champion led by the IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS electronically heated tobacco devices and Swedish Match’s General snus as Modified Risk Tobacco Products and renewal applications for these products are presently pending before the FDA.